182 related articles for article (PubMed ID: 26593376)
1. The triumph of chemically enhanced cellular reprogramming: a patent review.
Anwar MA; Kim S; Choi S
Expert Opin Ther Pat; 2016; 26(2):265-80. PubMed ID: 26593376
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs).
Singh VK; Kumar N; Kalsan M; Saini A; Chandra R
J Stem Cells; 2015; 10(1):43-62. PubMed ID: 26665937
[TBL] [Abstract][Full Text] [Related]
3. Integration-free reprogramming of human somatic cells to induced pluripotent stem cells (iPSCs) without viral vectors, recombinant DNA, and genetic modification.
Heng BC; Fussenegger M
Methods Mol Biol; 2014; 1151():75-94. PubMed ID: 24838880
[TBL] [Abstract][Full Text] [Related]
4. Current reprogramming systems in regenerative medicine: from somatic cells to induced pluripotent stem cells.
Hu C; Li L
Regen Med; 2016 Jan; 11(1):105-32. PubMed ID: 26679838
[TBL] [Abstract][Full Text] [Related]
5. Induced pluripotent stem cells reprogramming: Epigenetics and applications in the regenerative medicine.
Gomes KM; Costa IC; Santos JF; Dourado PM; Forni MF; Ferreira JC
Rev Assoc Med Bras (1992); 2017 Feb; 63(2):180-189. PubMed ID: 28355380
[TBL] [Abstract][Full Text] [Related]
6. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons.
Qi SD; Smith PD; Choong PF
ANZ J Surg; 2014 Jun; 84(6):417-23. PubMed ID: 24894037
[TBL] [Abstract][Full Text] [Related]
7. [From Gurdon to Yamanaka--a brief history of cell reprogramming].
Kubiak JZ; Ciemerych MA
Postepy Biochem; 2013; 59(2):124-30. PubMed ID: 24044277
[TBL] [Abstract][Full Text] [Related]
8. Induced Pluripotent Stem Cells in Disease Modelling and Regeneration.
Talug B; Tokcaer-Keskin Z
Adv Exp Med Biol; 2019; 1144():91-99. PubMed ID: 30414069
[TBL] [Abstract][Full Text] [Related]
9. A Revolution in Reprogramming: Small Molecules.
Zhou J; Sun J
Curr Mol Med; 2019; 19(2):77-90. PubMed ID: 30914022
[TBL] [Abstract][Full Text] [Related]
10. Reprogram or reboot: small molecule approaches for the production of induced pluripotent stem cells and direct cell reprogramming.
Jung DW; Kim WH; Williams DR
ACS Chem Biol; 2014 Jan; 9(1):80-95. PubMed ID: 24245936
[TBL] [Abstract][Full Text] [Related]
11. Veterinary applications of induced pluripotent stem cells: regenerative medicine and models for disease?
Cebrian-Serrano A; Stout T; Dinnyes A
Vet J; 2013 Oct; 198(1):34-42. PubMed ID: 24129109
[TBL] [Abstract][Full Text] [Related]
12. Roles of small molecules in somatic cell reprogramming.
Su JB; Pei DQ; Qin BM
Acta Pharmacol Sin; 2013 Jun; 34(6):719-24. PubMed ID: 23728722
[TBL] [Abstract][Full Text] [Related]
13. [Induced pluripotent stem cells: a new paradigm to study human tissues].
Sansac C; Assou S; Bouckenheimer J; LemaƮtre JM; De Vos J
Biol Aujourdhui; 2016; 210(1):1-8. PubMed ID: 27286575
[TBL] [Abstract][Full Text] [Related]
14. How far are induced pluripotent stem cells from the clinic?
Li M; Chen M; Han W; Fu X
Ageing Res Rev; 2010 Jul; 9(3):257-64. PubMed ID: 20362696
[TBL] [Abstract][Full Text] [Related]
15. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons.
Qi SD; Smith PD; Choong PF
ANZ J Surg; 2014 Jun; 84(6):E1-11. PubMed ID: 23035845
[TBL] [Abstract][Full Text] [Related]
16. Evolution of induced pluripotent stem cell technology.
Zhou H; Ding S
Curr Opin Hematol; 2010 Jul; 17(4):276-80. PubMed ID: 20442654
[TBL] [Abstract][Full Text] [Related]
17. Induced pluripotent stem cells and their implication for regenerative medicine.
Csobonyeiova M; Polak S; Koller J; Danisovic L
Cell Tissue Bank; 2015 Jun; 16(2):171-80. PubMed ID: 25037593
[TBL] [Abstract][Full Text] [Related]
18. Cell reprogramming: expectations and challenges for chemistry in stem cell biology and regenerative medicine.
Anastasia L; Pelissero G; Venerando B; Tettamanti G
Cell Death Differ; 2010 Aug; 17(8):1230-7. PubMed ID: 20168332
[TBL] [Abstract][Full Text] [Related]
19. Direct Reprogramming, Epigenetics, and Cardiac Regeneration.
Kurotsu S; Suzuki T; Ieda M
J Card Fail; 2017 Jul; 23(7):552-557. PubMed ID: 28529134
[TBL] [Abstract][Full Text] [Related]
20. Generation of Patient-Specific induced Pluripotent Stem Cell from Peripheral Blood Mononuclear Cells by Sendai Reprogramming Vectors.
Quintana-Bustamante O; Segovia JC
Methods Mol Biol; 2016; 1353():1-11. PubMed ID: 25523810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]